CN114668049A - 一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 - Google Patents
一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 Download PDFInfo
- Publication number
- CN114668049A CN114668049A CN202011548987.2A CN202011548987A CN114668049A CN 114668049 A CN114668049 A CN 114668049A CN 202011548987 A CN202011548987 A CN 202011548987A CN 114668049 A CN114668049 A CN 114668049A
- Authority
- CN
- China
- Prior art keywords
- parts
- sheep
- infant formula
- oligosaccharide
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020254 sheep milk Nutrition 0.000 title claims abstract description 38
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 35
- 239000000843 powder Substances 0.000 title claims abstract description 34
- 235000020256 human milk Nutrition 0.000 title claims abstract description 25
- 210000004251 human milk Anatomy 0.000 title claims abstract description 25
- 239000004615 ingredient Substances 0.000 title claims description 20
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 56
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 54
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 28
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 28
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 27
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 27
- 150000002270 gangliosides Chemical class 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 19
- 239000011707 mineral Substances 0.000 claims abstract description 19
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 11
- 239000008101 lactose Substances 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- 241001494479 Pecora Species 0.000 claims abstract description 10
- 239000005862 Whey Substances 0.000 claims abstract description 10
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 10
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 10
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 10
- 239000008158 vegetable oil Substances 0.000 claims abstract description 10
- 235000010755 mineral Nutrition 0.000 claims description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 9
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 235000000638 D-biotin Nutrition 0.000 claims description 3
- 239000011665 D-biotin Substances 0.000 claims description 3
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 235000010216 calcium carbonate Nutrition 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 239000011790 ferrous sulphate Substances 0.000 claims description 3
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 3
- 235000012680 lutein Nutrition 0.000 claims description 3
- 239000001656 lutein Substances 0.000 claims description 3
- 229960005375 lutein Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 235000019175 phylloquinone Nutrition 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 3
- 229960001898 phytomenadione Drugs 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- 229960000342 retinol acetate Drugs 0.000 claims description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims description 3
- 239000011770 retinyl acetate Substances 0.000 claims description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 235000011083 sodium citrates Nutrition 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 3
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 210000004556 brain Anatomy 0.000 abstract description 15
- 238000011161 development Methods 0.000 abstract description 12
- 235000013336 milk Nutrition 0.000 abstract description 4
- 239000008267 milk Substances 0.000 abstract description 4
- 210000004080 milk Anatomy 0.000 abstract description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052737 gold Inorganic materials 0.000 abstract description 3
- 239000010931 gold Substances 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000018109 developmental process Effects 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 230000004641 brain development Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003007 myelin sheath Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Dairy Products (AREA)
Abstract
本发明涉及婴幼儿配方奶粉，具体涉及一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉。其方案含有如下重量份配比的成分：全脂绵羊乳2200‑3000份，绵羊脱盐乳清粉50‑220份，乳糖200‑320份，植物油80‑140份，低聚果糖10‑14份、低聚半乳糖19‑26份、神经节苷脂2‑4份，DHA(二十二碳六烯酸)3.5‑5份、ARA(花生四烯酸)4.5‑8.5份、维生素4‑6份、矿物质10‑13份。本发明所添加的神经节苷脂与脑黄金组合(DHA和ARA)具有协同作用，在大脑迅速发育的关键时期，可使婴幼儿有效吸收，支持大脑结构和功能的发育。
Description
技术领域
本发明涉及配方奶粉，具体涉及一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉。
背景技术
母乳是婴幼儿生长发育过程中首选的营养最完全，最安全的天然食物。母乳的成分主要可以分为两大类，一是营养性成分；二是功能性成分。营养性成分主要是指为人体提供能量，比如乳糖、脂肪和蛋白质；而功能性成分则是指调节人体免疫机能、参与某些组织的修复的成分，比如，免疫球蛋白、乳铁蛋白、低聚糖、神经节苷脂等。但目前母乳的喂养率只在35％左右，因此婴幼儿配方食品则是维持婴幼儿特殊时期生长发育的重要营养来源。现阶段婴幼儿配方食品在模拟母乳的研究上主要集中于蛋白质、脂肪的结构组成趋于母乳化，而对于功能性成分母乳化的研究则相对较少。对母乳成分生理功能特性的深入了解,有助于更加完善婴幼儿食品的研制。在制备婴幼儿配方食品时,不仅要考虑其营养功能，同时也应注重其所具有的生物学意义,这也是婴幼儿食品的一个重要的研究方向。
婴幼儿配方乳粉的发展是以科学为基础的从组成到功能模拟的研发历程，从最初的能量、营养素含量模拟到第二代添加DHA/AA促进神经系统/视力/认知发育，再到现阶段最多的模拟母乳添加结构脂OPO、益生菌+益生元促进肠道功能，提升免疫力的配方，都是主要集中于结构组成母乳化，而对功能性成分母乳化的研究则较少。
发明内容
本发明是采用绵羊乳为基础原料开发的新婴幼儿配方奶粉，其方案如下：
一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2200-3000份，绵羊脱盐乳清粉50-220份，乳糖200-320份，植物油80-140份，低聚果糖10-14份、低聚半乳糖19-26 份、神经节苷脂2-4份，DHA(二十二碳六烯酸)3.5-5份、ARA(花生四烯酸)4.5-8.5份、维生素4-6份、矿物质10-13份。
本发明的另一优选方案是，一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2500-2800份，绵羊脱盐乳清粉100-150份，乳糖240-280份，植物油100-120份，低聚果糖12-13份、低聚半乳糖20-24份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7份、维生素4-6份、矿物质11-12份。
本发明的另一优选方案是，一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全全脂绵羊乳2650-2750 份，绵羊脱盐乳清粉110-130份，乳糖250-270份，植物油105-115份，低聚果糖12-13份、低聚半乳糖21-23份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7份、维生素4-6份、矿物质11-12份。
本发明的另一优选方案是，一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260份，植物油110份，低聚果糖12.5份、低聚半乳糖22份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4.5份、 ARA(花生四烯酸)6份、维生素5份、矿物质11.5份。
本发明的另一优选方案是，所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl-α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸，
本发明的另一优选方案是，维生素各组分的重量份比例为， 48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15 :0.24:0.02:7.96:0.88:25.22:0.98：5.83。
本发明的另一优选方案是，所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
本发明的另一优选方案是，所述矿物质里各成分的重量配比为： 22.7：25.5：1.9：1.2：37.1：7.8：2.3：0.94：0.09：0.71：0.033： 0.017。
新鲜的绵羊奶与母乳中的营养成分组成及构成比例还是存在一定差距，因此对绵羊奶配方要求较高，如何通过调节各组分的配比来使绵羊奶易于吸收并且满足宝宝营养和成长需求一直是业内的难题，本发明根据宝宝的生长发育特点，将功能性成分母乳化，专门研制了营养成分和功能更加接近母乳，易消化吸收，特别添加了脑部营养因子神经节苷脂等重要营养物质的以全绵羊乳为基础的婴幼儿配方绵羊奶粉，该产品融合了易消化的绵羊奶和丰富的营养成分，以满足婴幼儿在不同阶段的生长发育的营养需求。
(1)本发明是提供一种婴幼儿配方绵羊奶粉，以全绵羊乳配方结合添加脑部营养因子神经节苷脂，使得该配方乳粉在营养和功能成分组成上更接近母乳，营养丰富，易于消化吸收，满足婴幼儿特殊的营养需求。
(2)全绵羊乳配方，绵羊奶天然营养丰富，易于消化吸收(绵羊奶脂肪球颗粒小，中短链脂肪酸含量高，天然A2同类蛋白、天然含有乳铁蛋白、HMO,高含量乳钙及维生素B12、叶酸等)。
(3)本发明还特别添加了以下营养素：
DHA、ARA。利用DHA和ARA的比例组合，提供胎儿脑部发育的重要营养成分，保证婴幼儿的视力和神经系统发育。
(4)本发明所添加的神经节苷脂与脑黄金组合(DHA和ARA)具有协同作用，神经节苷脂和DHA、ARA共同参与大脑发育的一些关键过程，且大脑对这些营养素的需求与大脑发育的关键窗口期相契合，神经节苷脂与DHA、ARA共同参与的关键过程包括：脑细胞的生长发育；脑细胞连接的形成；神经髓鞘的形成。神经节苷脂是神经连接功能的关键。大脑的生长和成熟与神经节苷脂的增加有关。新生儿有1,000亿个没有连接的神经，当环境发生变化,如环境刺激和妈妈激发，越来越多的神经会发生连接，在关键期，高速的神经连接发生需要大量的神经节苷脂。神经连接有助于信息传递，从而加强学习力和记忆力；同时神经节苷脂还作用于神经连接两端的组成成分，因此，在脑细胞间电信号可从一端转换成化学信号，再从另一端转回电信号，确保连接已就绪，来接收信号、转换信号、再到下一个信号。
人体的脑部发育主要集中在胎儿和婴幼儿时期，新生宝宝脑重量仅有350-400克，大约是成人脑部重量的25％，而在3岁时大脑的发育将达到成人大小的80％。大脑的生长和发育贯穿着整个婴幼儿时期，且大脑的不同部分以不同的速度发育与成熟。孕期与婴幼儿期是大脑迅速生长和发育的时期，因为神经元在这个时期产生分叉，并发生连接形成网状结构，从而奠定学习和记忆的基础。本发明所添加的神经节苷脂与脑黄金组合(DHA和ARA)具有协同作用，在大脑迅速发育的关键时期，可使婴幼儿有效吸收，支持大脑结构和功能的发育。
具体实施方式
以下结合具体实施例对本发明作进一步的说明，本发明的保护范围并不仅限于这些实施例。
实施例1
一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：
含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260份，植物油110份，低聚果糖12.5份、低聚半乳糖22 份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4.5份、ARA(花生四烯酸)6份、维生素5份、矿物质11.5份。
其中，所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl- α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸，维生素各组分的重量份比例为，
48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15 :0.24:0.02:7.96:0.88:25.22:0.98：5.83。
所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
矿物质里各成分的重量配比为：22.7：25.5：1.9：1.2：37.1：7.8： 2.3：0.94：0.09：0.71：0.033：0.017。
上述实施例为本发明的实施方式，但本发明的实施方式并不受上述实施例的限制，其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化，均应为等效的置换方式，都包含在本发明的保护范围之内。
Claims (8)
1.一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2200-3000份，绵羊脱盐乳清粉50-220份，乳糖200-320份，植物油80-140份，低聚果糖10-14份、低聚半乳糖19-26份、神经节苷脂2-4份，DHA(二十二碳六烯酸)3.5-5份、ARA(花生四烯酸)4.5-8.5份、维生素4-6份、矿物质10-13份。
2.根据权利要求1所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2500-2800份，绵羊脱盐乳清粉100-150份，乳糖240-280份，植物油100-120份，低聚果糖12-13份、低聚半乳糖20-24份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7份、维生素4-6份、矿物质11-12份。
3.根据权利要求2所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2650-2750份，绵羊脱盐乳清粉110-130份，乳糖250-270份，植物油105-115份，低聚果糖12-13份、低聚半乳糖21-23份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7份、维生素4-6份、矿物质11-12份。
4.根据权利要求3所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260份，植物油110份，低聚果糖12.5份、低聚半乳糖22份、神经节苷脂3.5份，DHA(二十二碳六烯酸)4.5份、ARA(花生四烯酸)6份、维生素5份、矿物质11.5份。
5.根据权利要求1-4任意一项权利要求所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl-α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸。
6.根据权利要求5所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，所维生素各组分的重量份比例为，48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15:0.24:0.02:7.96:0.88:25.22:0.98：5.83。
7.根据权利要求1-4任意一项权利要求所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
8.根据权利要求7所述的添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉，其特征在于，所所述矿物质里各成分的重量配比为：22.7：25.5：1.9：1.2：37.1：7.8：2.3：0.94：0.09：0.71：0.033：0.017。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011548987.2A CN114668049A (zh) | 2020-12-24 | 2020-12-24 | 一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011548987.2A CN114668049A (zh) | 2020-12-24 | 2020-12-24 | 一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114668049A true CN114668049A (zh) | 2022-06-28 |
Family
ID=82070569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011548987.2A Pending CN114668049A (zh) | 2020-12-24 | 2020-12-24 | 一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114668049A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104996576A (zh) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | 一种婴幼儿羊奶粉及其制备方法 |
| CN105532883A (zh) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | 一种婴幼儿用配方羊奶粉及其制备方法 |
| CN105558059A (zh) * | 2015-12-16 | 2016-05-11 | 海普诺凯营养品有限公司 | 一种婴幼儿配方羊奶粉及其制备方法 |
| CN110074190A (zh) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | 一种用脱脂羊奶粉生产的婴幼儿配方羊奶粉 |
-
2020
- 2020-12-24 CN CN202011548987.2A patent/CN114668049A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104996576A (zh) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | 一种婴幼儿羊奶粉及其制备方法 |
| CN105558059A (zh) * | 2015-12-16 | 2016-05-11 | 海普诺凯营养品有限公司 | 一种婴幼儿配方羊奶粉及其制备方法 |
| CN105532883A (zh) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | 一种婴幼儿用配方羊奶粉及其制备方法 |
| CN110074190A (zh) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | 一种用脱脂羊奶粉生产的婴幼儿配方羊奶粉 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barness et al. | Commentary on breast-feeding and infant formulas, including proposed standards for formulas | |
| AU2010203123B2 (en) | Infant formula containing nucleotides | |
| CN102422900A (zh) | 促进脂肪酸和钙吸收的配方奶粉及其制备方法 | |
| CN110742130A (zh) | 一种添加模拟母乳脂肪结构的脂质体的婴幼儿配方羊奶粉及其制备方法 | |
| CN102524421B (zh) | 婴幼儿酸碱平衡配方奶粉及其制备方法 | |
| US20120276057A1 (en) | Nutritional composition for supporting brain development and function of toddlers | |
| CN105558059A (zh) | 一种婴幼儿配方羊奶粉及其制备方法 | |
| CN110754530A (zh) | 一种有效促进儿童身高发育的配方奶粉及生产方法 | |
| CN101869151B (zh) | 一种含乳凝集素的婴幼儿奶粉及其制备方法 | |
| CN101946826A (zh) | 一种针对偏食婴幼儿及儿童的配方奶粉及其生产方法 | |
| CN102845536A (zh) | 一种新生婴儿免疫配方奶粉 | |
| Guo | Chemical composition of human milk | |
| CN101878819B (zh) | 一种含脂联素的婴幼儿配方奶粉及其制备方法 | |
| CN114668049A (zh) | 一种添加模拟母乳功能性成分的婴幼儿配方绵羊奶粉 | |
| CN113678898A (zh) | 一种有助于儿童发育成长的奶粉及其制备方法 | |
| US20210037854A1 (en) | Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive | |
| CN105918494A (zh) | 一种豆基婴儿配方粉 | |
| Park | Human milk | |
| CN109874744A (zh) | 一种孕妇乳母富微营养素鲜鸡蛋的生产方法 | |
| CN115104731B (zh) | 营养组合物以及包含所述营养组合物的食品 | |
| CN114668044A (zh) | 一种婴幼儿配方绵羊奶粉 | |
| CN109874870A (zh) | 一种模拟母乳蛋白组成和免疫功能的婴儿乳粉 | |
| CN115191604A (zh) | 一种营养组合物和包含营养组合物的食品及应用 | |
| Morley | Breast feeding and cognitive outcome in children born prematurely | |
| Jelliffe et al. | Commentary: Recommended dietary allowances for infants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220628 |
|
| RJ01 | Rejection of invention patent application after publication |